Influenza Diagnostics Market Outlook, Global Demand And Rising Trends 2020 – 2025
Influenza Diagnostics Market is valued at USD 558.06 Million in 2018 and expected to reach USD 907.92 Million by 2025 with the CAGR of 7.2% over the forecast period.
A research report on Influenza Diagnostics Market features a succinct analysis on the latest market trends. The report also includes detailed abstracts about statistics, revenue forecasts and market valuation, which additionally highlights its status in the competitive landscape and growth trends accepted by major industry players.
Key Players Influenza Diagnostics:
Roche Diagnostics
Princeton BioMedtech corp
Meridian Bioscience, Inc
Becton Dickinson and Company Sekisui Diagnostics
Thermo Fisher Scientific. SA Scientific Inc
Alere Scarborough, Inc
Quidel Corporation
Others.
Influenza Diagnostics Market Dynamics –
Increasing prevalence of infectious diseases, seasonal influenza, the growing amount of research and development, are some major factor contributing to the revenue growth of the influenza diagnostics market across the world. According to report by NCBI, the World Health Organization (WHO) estimates that approximately one billion people are infected and up to 500,000 people die from influenza each year in the world. Influenza is measured to be the greatest killer of the human populations. According to WHO, these annual epidemics were estimated to result in about 3 to 5 million cases of severe illness and about 290 000 to 650 000 respiratory deaths worldwide. Moreover, growing awareness about the influenza globally is expected to further drive growth of the global influenza diagnostics market over the forecast period. According to World Health Organization statistics, 1.4 million people worldwide suffer from infections acquired in hospitals. However, increasing prices of diagnostic kits and reagents will hamper the growth of influenza diagnostics market. Moreover, technological advancements in healthcare sectors and increasing government initiatives and collaboration with market players for raising awareness regarding the innovative and more effective faster, accurate and cost-effective diagnosis for disease will create wide opportunities for the players operating in the influenza diagnostics market during forecast period.
Influenza Diagnostics Market Regional Analysis –
North America is expected to dominate influenza diagnostics market with the potential rate due to technological advancements, health awareness among population, government initiatives to control the disease rates and increase in number of research collaborations, increases infectious diseases like seasonal flu and pandemic influenza and rising awareness among the people about pandemics. These are some of the drivers expected to accelerate the regional market growth. The U.S. Centers for Disease Control (CDC) found between about 6 million and 7 million people with flu cases in the U.S. in 2019. According to The Centers for Disease Control and Prevention, around 15.5 million number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis in the United States. As per National Center for Biotechnology Information (NCBI), more than 18 million people work in the healthcare field in the United States. Moreover, increasing number of players entering the influenza diagnostics market with quality products offerings market region. As per CDC, influenza testing across the United States may be higher than normal at this time of year because of the COVID-19 pandemic.
Europe is second largest market for influenza diagnostics and is growing due to increased growth in research and development activities as well rapidly spreading infectious disease in regions. For instance, WHO-Europe, March 2020, approximately infected cases 171,874 and deaths 8,744. According to NCBI, around 10 million individuals aged 65 years and older are at risk of contracting influenza, and it can be estimated that the lack of a vaccination strategy would lead to more than 2 million cases and about 30,000 deaths in Italy. And the demand of the influenza diagnostics will accelerate due rapidly increasing infections during forecast period.
The Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period with due to the increase in healthcare expenditure, rising awareness about infectious diseases, higher rate of population, rising initiatives by government bodies to control the disease rate, increasing number of hospitals &laboratories, rising awareness about early diagnosis. China has witnessed increasing prevalence of infectious diseases. For example, according to WHO-China, China reported 2478 new cases of COVID-19. Due to these factors Asia Pacific market would be a fruitful investment for the influenza diagnostics market contributors. Additionally, favorable government initiatives and increase in number of research collaborations are some of the drivers expected to accelerate the market growth.
Key Benefits for Influenza Diagnostics Market Reports –
Global Market report covers in depth historical and forecast analysis.
Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Market report helps to identify opportunities in market place.
Global Market report covers extensive analysis of emerging trends and competitive landscape.
Influenza Diagnostics Market Segmentation –
By Test Type: Reverse transcription polymerase chain reaction (RT-PCR) , Rapid Antigen Testing, Cell Culture, Others (Immunofluorescence & Serology)
By End-User: Hospitals, Research Centers, Diagnostic Laboratories, Point of care testing centres (POCT)
Get Sample Copy of This Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12875&RequestType=Sample